Setterwalls advised Promore Pharma AB on the deal.Promore Pharma AB completed its rights issue of approximately SEK 48.6 million. Promore Pharma is a biopharmaceutical company specialized…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
